ARVN Free Cash Flow
-$208.80MTTM · USD
Period ending:
ARVN FY Free Cash FlowUSD
$554.70M-$350.70M
2016-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ARVN free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| -275,700,000 | |
| -261,100,000 | |
| -350,700,000 | |
| -280,300,000 | |
| 554,700,000 | |
| -96,204,467 | |
| -46,870,366 | |
| -18,948,331 | |
| 4,100,666 | |
| -19,709,796 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All ARVN financial metrics · ARVN stock overview · How to interpret financial metrics
